Trademark Overview
On Tuesday, March 3, 2026, a trademark application was filed for RELIADERM with the United States Patent and Trademark Office. The USPTO has given the RELIADERM trademark a serial number of 99680218. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 3, 2026. This trademark is owned by ICON HEALTH SCIENCE, LLC. The RELIADERM trademark is filed in the Pharmaceutical Products category with the following description:
Dermatological pharmaceutical products; Dermatological preparations; Gels for dermatological use; Creams for dermatological use; Medicated ointments for treating dermatological conditions; Medicated creams for treating dermatological conditions; Medicated lotions for treating dermatological conditions; Pharmaceutical preparations for skin wounds; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Pharmaceutical preparations for treating sunburn; Medicated sunburn lotions; Pharmaceutical preparations for treating skin disorders; Medicated diaper rash ointment; Medicated baby powders; Pharmaceutical preparations for the treatment of pressure sores; Pharmaceutical preparations for the treatment of eczema, psoriasis, rosacea, sunburn, atopic dermatitis, contact dermatitis, seborrheic dermatitis, perioral dermatitis, acne, hyperpigmentation, melasma, xerosis, diaper rash, cradle cap, heat rash, windburn, skin wounds, surgical scars, and skin burns; ...
